OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $182,000 | -42.6% | 422,161 | -25.1% | 0.00% | – |
| Q1 2016 | $317,000 | -72.0% | 563,503 | -14.5% | 0.00% | – |
| Q4 2015 | $1,133,000 | -36.4% | 658,727 | -22.0% | 0.00% | -100.0% |
| Q3 2015 | $1,782,000 | -56.6% | 844,741 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $4,103,000 | +53.3% | 828,951 | +142.5% | 0.00% | 0.0% |
| Q1 2015 | $2,677,000 | -46.4% | 341,890 | -58.5% | 0.00% | 0.0% |
| Q4 2014 | $4,992,000 | -9.6% | 823,694 | -36.4% | 0.00% | 0.0% |
| Q3 2014 | $5,520,000 | +262.2% | 1,295,887 | +425.4% | 0.00% | – |
| Q2 2014 | $1,524,000 | +303.2% | 246,647 | +323.5% | 0.00% | – |
| Q1 2014 | $378,000 | -77.8% | 58,242 | -80.7% | 0.00% | – |
| Q4 2013 | $1,702,000 | -47.8% | 302,270 | -43.2% | 0.00% | -100.0% |
| Q3 2013 | $3,260,000 | +583.4% | 531,846 | +552.4% | 0.00% | – |
| Q2 2013 | $477,000 | -62.6% | 81,527 | -66.4% | 0.00% | -100.0% |
| Q4 2012 | $1,274,000 | -10.5% | 242,680 | -2.6% | 0.00% | 0.0% |
| Q3 2012 | $1,423,000 | +565.0% | 249,056 | +545.0% | 0.00% | – |
| Q2 2012 | $214,000 | -22.5% | 38,612 | -42.6% | 0.00% | – |
| Q1 2012 | $276,000 | – | 67,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |